Ligand Pharmaceuticals | Eigenkapital Und Reserven



Equity Capital And Reserves Veränderung Datum
Amgen USD 7.43B 1.22B 2025-06
Arrowhead Research USD 522.31M 161.91M 2025-06
Baxter International USD 7.05B 90M 2025-03
Bristol-Myers Squibb USD 17.49B 100M 2025-06
Eli Lilly USD 18.27B 2.43B 2025-06
Gilead Sciences USD 19.67B 596M 2025-06
GlaxoSmithKline GBP 14.35B 197M 2025-06
Glaxosmithkline GBP 13.67B 337M 2024-12
Insmed USD 1.25B 1.15B 2025-06
Ionis Pharmaceuticals USD 631.72M 156M 2025-06
Ligand Pharmaceuticals USD 828.53M 32.99M 2025-06
MacroGenics USD 116.06M 4.01M 2024-12
Merck USD 49.06B 725M 2025-06
Pacira USD 757.77M 40.77M 2025-06
Pfizer USD 88.7B 1.64B 2025-06
Veracyte USD 1.22B 26.12M 2025-06


Ligand Pharmaceuticals Eigenkapital Und Reserven - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.